33. Werkmeister JA, Triglia T, Mackay IR, et al. Fluctuations in the expression of a glyolipid antigen assocted with differentiation of melanoma cells monitored by a monoclonal antibody , Leo Me13. Cancer Res, 1987,47：225
34. 田芳金伯泉黄传书,等.抗人黑素瘤单克隆抗体免疫组化的研究.单克隆抗体通迅,1991,7：21
35. Estin CD, Plowman CD, Rose TM, et al. Characterization of P97, a human melanoma -associated antigen, and development of a recombinant vaccien for melanoma. In：Human Melanoma. From basic research to clinical application . Ferrone Sed. New York. Springer –Verlag, 1990.87
36.高天文刘荣卿叶庆佾.无色素性恶性黑素瘤免疫组化诊断研究.中华皮肤科杂志,1992, 25：222
37. 刘荣卿高天文.无色素性恶性黑素瘤的诊断探讨.实用肿瘤杂志,1992,7：152
38.Nagata H, Ueki H, Moriguchi T, et al. Fibronectin,localization in normal human skin, granulation tissue, hypertropic scar, maure scar, progressive systemic sclerotic skin, and other fibrosing dermatoses. Arch Dermatol, 1985, 121(8)：995～999
39. Linares HA. Protroglycan – lymphocyte association in the development of hypertrophic scars. Burns, 1990, 16(1)：21～24
40. Branchet MC, Boisnic S, Bletry O, et al. Exxpression of HLA class II antigenson skin fibroblasts in scleroderma. Br J Dermatol, 1992,12(5)：431～435
41.Castagnoli C, Stella M, Magliacani G, et al. Anomalous expression of HLA class II molecules on kerattinocytes and fibroblasts in hypdrtropgicscars consequent to thermal injury. Clin Exp Immunol, 1990, 82(2)：350～354
42. Needleman BW, Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patientl. Arthritis Rheum,1990, 33(12)：1847～1851
43. Skalli U, Schurch W, Seemayer T, et al. Myofibrollasts from diverse pathologic setting are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest, 1989, 60(2)：275
44. Sollberg S, Peltonen J, Uitto J, et al. Elevated expressoin of β２and β2integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with sysytemic sclerosis of recent onset .Arthritis Rheum, 1992；35(3)：290～298
45. Gay S, Jones RE, Huang GQ, et al. Immunohistologic demonstration of platelet - derives growth factor and sis – oncogene expression in scleroderma. J Invest Dermatol, 1989, 92(2)：301～303
46. Klareskog L, Gustafsson R, Scheynius A, et al. Increased expression of platelet – derives growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum, 1990, 94(2)：197～203
47. Gruschwitz M, Muller PU, Sepp N, et al. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis：amediator of fibrosis? J Invest Dermatol, 1990, 94(2)：197～203
48. Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagengene expression in keloids ：colocalization of type I and IV collagen and transforming growth factor –β1mRNA.J Invest Dermatol, 1991；97(2)：240～248
49.Trani AMA, Gruber BL, Kaufman LD, et al. Mast cell changes in scleroderma. Arthritis Rheum, 1992；35(8)：933～939
50. Hashimoto K, et al. Anti – keratin monoclonal antibodies ：production, specificities and applications. J Cutan Pathol, 1983；6(10)：529～539
51.Kallioinen M, et al. β-2-microglobulin in benign and malignant adnexal skin tumors and metastasizing basocellular carcinoma. J Cutan Pathol, 1984；1(11)：27～34
52. Penney NS. Immunohistochemistry of adnexal neoplasms. j Cutan Pathol , 1984；(11)：357～364
53.Swanson PE, et al. Eccrine sweat gland carcarcinoma：an histologic and immunohistochemical study of 32 cases. J Cutan Pathol,1987,2(4)：65～86
54. Noda Y, et al. Immunohistochemical study of carbonic anhydrase in mixed tumors and adenomas of sweat and sebaceous glands. J Cutan Pathol, 1987；5(14)：285～290
55.NodaY, et al. Immunohistochemical localization by monoclonal antibody of human epidermal growth factor in mixed tumors of the skin. J Cutan Pathol, 1987；6(14)：337～342
56. Zuk JA, et al. Immunohistochemistry staining patterns of sweat glands and their neoplasms using two nomoclonal antibodies to keratieos. j Cutan Pathol, 1988；1(15)：8～17
57.Mazoujian G, et al. Immunohistochemistry of gross disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am j Dermatopathol, 1988, 1(10)：28～35
58. Wood WS, et al. Mammary Paget’s disease and intraductal carcinoma ：histologic, histologic, histochemical and immunocytochemical comparison. Am j Dermatopathol, 1988, 10(3)：188
59. Mihara M. Chondroid syringoma associated with hidrocystoma – like changes ：possible differentiation into eccring gland：a histologic. immunohistochemical and electron microscopic study. J Cutan Pathol, 1989, 5(16)：281～286
60. Penneys NS, et al. Immunohistochemistry demonstration of ferritin in sweat gland and sweat gland neoplasms. J Cutan Pathol, 1990, 1(17)：32～36
61. Urano Y, et al. Immunohistochemistry demonstration of petidylarginine deiminase in human sweat glands. Am J Dermatopathol, 1990；12(3)：249～255
62. Mazoujian G. Immunohistochemistry of GCDFP –24 and zinic alpha2 glycoprotein in benign sweat gland tumors. Am J Dermatopathol,1990, 12(5)：452～457
刘季和 孙建方 曾学思 刁庆春
刘荣卿 聂祝湘 同天文 何威